NUVA Nuvasive Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NUVA

Price (delayed)

$56.8

Market cap

$2.93B

P/E Ratio

1,893.33

Dividend/share

N/A

EPS

$0.03

Enterprise value

$3.73B

NuVasive, Inc. is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. ...

Highlights
Nuvasive's net income has soared by 148% YoY and by 104% from the previous quarter
NUVA's EPS has soared by 133% YoY and by 103% QoQ
The equity has contracted by 6% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.nuvasive.com
Peers: OFIX ATEC SYK GMED

Key stats

What are the main financial stats of NUVA
Market
Shares outstanding
51.66M
Market cap
$2.93B
Enterprise value
$3.73B
Valuations
Price to earnings (P/E)
1,893.33
Price to book (P/B)
3.49
Price to sales (P/S)
2.54
EV/EBIT
60.36
EV/EBITDA
18.07
EV/Sales
3.24
Earnings
Revenue
$1.15B
EBIT
$61.86M
EBITDA
$206.62M
Free cash flow
$125.05M
Per share
EPS
$0.03
Free cash flow per share
$2.43
Book value per share
$16.28
Revenue per share
$22.36
TBVPS
$23.88
Balance sheet
Total assets
$2.15B
Total liabilities
$1.31B
Debt
$1.01B
Equity
$840.9M
Working capital
$572.02M
Liquidity
Debt to equity
1.2
Current ratio
3.95
Quick ratio
2.18
Net debt/EBITDA
3.87
Margins
EBITDA margin
17.9%
Gross margin
72.3%
Net margin
0.2%
Operating margin
6.1%
Efficiency
Return on assets
0.1%
Return on equity
0.2%
Return on invested capital
3.4%
Return on capital employed
3.2%
Return on sales
5.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NUVA stock price

How has the Nuvasive stock price performed over time
Intraday
-1.34%
1 week
1.32%
1 month
-10.07%
1 year
8.48%
YTD
0.83%
QTD
-5.1%

Financial performance

How have Nuvasive's revenue and profit performed over time
Revenue
$1.15B
Gross profit
$833.81M
Operating income
$70.37M
Net income
$1.85M
Gross margin
72.3%
Net margin
0.2%
NUVA's operating margin has soared by 190% since the previous quarter
The net margin has soared by 150% YoY and by 104% from the previous quarter
Nuvasive's net income has soared by 148% YoY and by 104% from the previous quarter
The gross profit has grown by 13% from the previous quarter and by 11% YoY

Growth

What is Nuvasive's growth rate over time

Valuation

What is Nuvasive stock price valuation
P/E
1,893.33
P/B
3.49
P/S
2.54
EV/EBIT
60.36
EV/EBITDA
18.07
EV/Sales
3.24
NUVA's EPS has soared by 133% YoY and by 103% QoQ
NUVA's price to book (P/B) is 11% less than its 5-year quarterly average of 3.9
The equity has contracted by 6% YoY
The price to sales (P/S) is 12% lower than the 5-year quarterly average of 2.9 and 9% lower than the last 4 quarters average of 2.8
Nuvasive's revenue has increased by 9% from the previous quarter and by 8% YoY

Efficiency

How efficient is Nuvasive business performance
The return on assets has surged by 150% year-on-year and by 105% since the previous quarter
The company's return on equity has surged by 150% YoY and by 104% QoQ
NUVA's ROS is up by 38% YoY
The company's return on invested capital rose by 21% YoY

Dividends

What is NUVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NUVA.

Financial health

How did Nuvasive financials performed over time
The total assets is 64% greater than the total liabilities
NUVA's current ratio has surged by 115% year-on-year and by 14% since the previous quarter
NUVA's quick ratio has surged by 56% year-on-year and by 11% since the previous quarter
The debt is 20% more than the equity
The debt has contracted by 33% YoY
NUVA's debt to equity is down by 29% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.